PCR104 How Do Chinese Draft Guidelines (2021) on Patient Focused Drug Development Compare with Those of EMA and FDA?
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.1882
https://www.valueinhealthjournal.com/article/S1098-3015(23)01982-4/fulltext
Title :
PCR104 How Do Chinese Draft Guidelines (2021) on Patient Focused Drug Development Compare with Those of EMA and FDA?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01982-4&doi=10.1016/j.jval.2023.03.1882
First page :
Section Title :
Open access? :
No
Section Order :
11205